252 related articles for article (PubMed ID: 34818088)
1. A harm reduction model to assess the impact of new treatments for pain over standard of care among patients with osteoarthritis.
Silverman S; Schepman P; Rice JB; Robinson RL; White AG; Fernan C; Beck CG
J Manag Care Spec Pharm; 2021 Dec; 27(12):1652-1660. PubMed ID: 34818088
[No Abstract] [Full Text] [Related]
2. Prescription opioid utilization patterns, and associated outcomes, among privately insured patients prescribed opioids to manage pain associated with osteoarthritis.
Schepman P; Rice JB; Beck CG; White A; Robinson RL; Thakkar S; Fernan C; Emir B; Silverman S
Curr Med Res Opin; 2023 Aug; 39(8):1147-1156. PubMed ID: 37435803
[TBL] [Abstract][Full Text] [Related]
3. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
[TBL] [Abstract][Full Text] [Related]
4. Impact of Pain Severity and Opioid Use on Health Care Resource Utilization and Costs Among Patients with Knee and Hip Osteoarthritis.
Wei W; Gandhi K; Blauer-Peterson C; Johnson J
J Manag Care Spec Pharm; 2019 Sep; 25(9):957-965. PubMed ID: 31456495
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.
Katz JN; Smith SR; Collins JE; Solomon DH; Jordan JM; Hunter DJ; Suter LG; Yelin E; Paltiel AD; Losina E
Osteoarthritis Cartilage; 2016 Mar; 24(3):409-18. PubMed ID: 26525846
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis.
da Costa BR; Pereira TV; Saadat P; Rudnicki M; Iskander SM; Bodmer NS; Bobos P; Gao L; Kiyomoto HD; Montezuma T; Almeida MO; Cheng PS; Hincapié CA; Hari R; Sutton AJ; Tugwell P; Hawker GA; Jüni P
BMJ; 2021 Oct; 375():n2321. PubMed ID: 34642179
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
Wielage RC; Bansal M; Andrews JS; Klein RW; Happich M
Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
[TBL] [Abstract][Full Text] [Related]
8. Analgesic utilization in people with knee osteoarthritis: A population-based study using primary care data.
Taqi A; Gran S; Knaggs RD
Pain Pract; 2023 Jun; 23(5):523-534. PubMed ID: 36808813
[TBL] [Abstract][Full Text] [Related]
9. Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis.
Gore M; Sadosky A; Leslie D; Tai KS; Seleznick M
Clin Ther; 2011 Dec; 33(12):1914-31. PubMed ID: 22088416
[TBL] [Abstract][Full Text] [Related]
10. Tramadol for osteoarthritis.
Toupin April K; Bisaillon J; Welch V; Maxwell LJ; Jüni P; Rutjes AW; Husni ME; Vincent J; El Hindi T; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2019 May; 5(5):CD005522. PubMed ID: 31132298
[TBL] [Abstract][Full Text] [Related]
11. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.
Hochberg MC; Altman RD; April KT; Benkhalti M; Guyatt G; McGowan J; Towheed T; Welch V; Wells G; Tugwell P;
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):465-74. PubMed ID: 22563589
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
Pelletier JP; Martel-Pelletier J; Rannou F; Cooper C
Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S22-7. PubMed ID: 26806184
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of tramadol/acetaminophen combination tablets (Ultracet®) as add-on and maintenance therapy in knee osteoarthritis pain inadequately controlled by nonsteroidal anti-inflammatory drug (NSAID).
Park KS; Choi JJ; Kim WU; Min JK; Park SH; Cho CS
Clin Rheumatol; 2012 Feb; 31(2):317-23. PubMed ID: 21811797
[TBL] [Abstract][Full Text] [Related]
14. Therapy switching, augmentation, and discontinuation in patients with osteoarthritis and chronic low back pain.
Gore M; Sadosky AB; Leslie DL; Tai KS; Emery P
Pain Pract; 2012 Jul; 12(6):457-68. PubMed ID: 22230466
[TBL] [Abstract][Full Text] [Related]
15. All-Cause Health Care and Work Loss Burden Associated With Nonsteroidal Anti-Inflammatory Drug and Opioid Treatment in Employed Patients With Osteoarthritis.
Silverman S; Thakkar S; Sell H; White AG; Downes N; Pajerowski W; Robinson RL; Beck CG; Emir B; Schepman P
J Occup Environ Med; 2022 Aug; 64(8):699-706. PubMed ID: 35732028
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
17. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States.
White AG; Birnbaum HG; Janagap C; Buteau S; Schein J
J Occup Environ Med; 2008 Sep; 50(9):998-1005. PubMed ID: 18784547
[TBL] [Abstract][Full Text] [Related]
18. Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER).
Ambrosini A; Estemalik E; Pascual J; Rettiganti M; Stroud C; Day K; Ford J
J Manag Care Spec Pharm; 2022 Jun; 28(6):645-656. PubMed ID: 35451858
[No Abstract] [Full Text] [Related]
19. Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review.
Smith SR; Deshpande BR; Collins JE; Katz JN; Losina E
Osteoarthritis Cartilage; 2016 Jun; 24(6):962-72. PubMed ID: 26844640
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
